首页> Frontiers in immunology> Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center.

Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center.

导出 LinkOut

翻译打印收藏纠错

第一作者： Danqing,Kong

第一单位： National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.

作者： Danqing,Kong ^[1] ; Nana,Ping ^[1] ; Xin,Gao ^[2] ; Rui,Zou ^[3] ; Peng,Wang ^[1] ; Depei,Wu ^[1] ; Zhengming,Jin ^[1] ; Changju,Qu ^[1]

作者单位： National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China. ^[1] Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China. ^[2] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. ^[3]

关键词 HBV reactivation chimeric antigen receptor T cell therapy cirrhosis diffuse large B cell lymphoma hepatitis B virus

医学主题词人类(Humans);回顾性研究(Retrospective Studies);乙型肝炎, 慢性(Hepatitis B, Chronic);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse)

DOI 10.3389/fimmu.2023.1200748

PMID 37292195

发布时间 2023-06-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交